Current role
Karen Cashmere
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Karen Cashmere
ZyVersa Therapeutics, Inc. reported in an 8-K filed December 13, 2022 that Karen Cashmere was appointed Chief Commercial Officer. ZyVersa Therapeutics, Inc. reported in an 8-K filed December 13, 2022 that Karen Cashmere was appointed Chief Commercial Officer, effective December 12, 2022.
“Karen Cashmere was appointed Chief Commercial Officer”
“Karen Cashmere was appointed Chief Commercial Officer”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-12-12–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at ZyVersa Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Stephen C. Glover CEO, Board Member
- Peter Wolfe CFO
- Daniel J. O'Connor Board Member
- Gregory Freitag Board Member
- James Sapirstein Board Member
- Katrin Rupalla Board Member
- Min Chul Park, Ph.D. Board Member
- Min-Chul Park Board Member
- Rob G. Finizio Board Member
- Robert Finizio Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.